CASI Pharmaceuticals, Inc. (CASIF) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$20.75M | +29.0% |
| 2024 | -$29.22M | -46.4% |
| 2023 | -$19.97M | +5.3% |
| 2022 | -$21.09M | +21.4% |
| 2021 | -$26.84M | -3.7% |
| 2020 | -$25.89M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$20.75M | +29.0% |
| 2024 | -$29.22M | -46.4% |
| 2023 | -$19.97M | +5.3% |
| 2022 | -$21.09M | +21.4% |
| 2021 | -$26.84M | -3.7% |
| 2020 | -$25.89M | — |